Hydroxychloroquine (HCQ) lowered mortality in a study of 2,541 COVID-19 cases in Michigan at the Henry Ford Health System. The Henry Ford study is reputable (“The Henry Ford Health System (HFHS) in Southeast Michigan: large six hospital integrated health system…” The sample is large (“Consecutive patients hospitalized with a COVID-related admission in the health system from March 10,2020 to May 2,2020 were included.” “2,541 patients”). The study controlled the medications. Several statistical tests were correctly conducted. Cardiac and in-hospital monitoring was an essential feature of the treatment. This was not out-patient treatment. Hydroxychloroquine (HCQ) cut mortality significantly. “In this multi-hospital … Continue reading Important Hydroxychloroquine Benefit News